Beyond Data Logs: Capturing The Real-World Experience Of Medical Devices At Home
Devices can send information back to a physician, but that data doesn’t explain how the…
Beyond Data Logs: Capturing The Real-World Experience Of Medical Devices At Home
Devices can send information back to a physician, but that data doesn’t explain how the experience felt. Without that context, healthcare teams miss the very details that shape adherence, satisfaction, and long-term outcomes. The post Beyond Data Logs: Capturing The Real-World Experience Of Medical Devices At Home appeared first on MedCity News.
Beyond Data Logs: Capturing The Real-World Experience Of Medical Devices At Home
Devices can send information back to a physician, but that data doesn’t explain how the experience felt. Without that context, healthcare teams miss the very details that shape adherence, satisfaction, and long-term outcomes. The post Beyond Data Logs: Capturing The Real-World Experience Of Medical Devices At Home appeared first on MedCity News.
Debunked Autism Claims Resurface After Press Conference, And Supreme Court to Hear Cases on Conversion Therapy and School Vaccine Mandates — The Monitor
This volume analyzes false narratives about autism rates in Cuba and among Amish people in the U.S.; health-related cases before the Supreme Court, including challenges to bans on conversion therapy for LGBTQ+ minors and school vaccine mandates; and the limitations of AI chatbots as primary sources of health information.
University of California Researchers, Patients Wary of Trump Cuts Even as Some Dollars Flow Again
In August, an 80-year-old woman walked into the emergency room at Ronald Reagan UCLA Medical Center. She was lucid but experiencing a stroke. Within minutes, doctors asked for permission to pull out the stroke-causing clot before any more brain damage could occur. She hesitated. The procedure was part of a clinical trial, and she’d heard…
Listen: Why “TrumpRx” Might Not Save You Money
KFF Health News chief Washington correspondent Julie Rovner appeared Oct. 6 on the podcast “Today, Explained” to discuss TrumpRx, President Donald Trump’s proposal for a direct-to-consumer website aimed at lowering prescription drug costs. While few details were made public when the program was announced on Sept. 30, Rovner explains that consumers who are enrolled in…
KFF Tracking Poll on Health Information and Trust: Tylenol-Autism Link and Vaccine Policies
Following the Trump administration’s warning last month that using acetaminophen – the active ingredient in Tylenol – during pregnancy can increase the risk of autism in children, very few adults say the claim about a causal relationship is “definitely true,” though much of the public is uncertain whether to believe it. Trust in the CDC…
Poll: After President Trump’s Warning, Many People Are Uncertain About Whether Tylenol Use in Pregnancy Causes Autism; Most Republicans Say It Is Probably or Definitely True
Following the Trump administration’s warning last month that using acetaminophen – the active ingredient in Tylenol – during pregnancy can increase the risk of autism in children, very few (4%) adults say the claim about a causal relationship is “definitely true,” a new KFF Tracking Poll on Health Information and Trust finds.
HealthTap Joins LillyDirect to Expand Access to Primary Care–Led Diabetes Treatment
HealthTap is now offering virtual primary care for patients with diabetes on LillyDirect, becoming the platform’s first primary care provider. The post HealthTap Joins LillyDirect to Expand Access to Primary Care–Led Diabetes Treatment appeared first on MedCity News.
Will the UK (finally) increase drug prices?
President Trump’s May 12 Executive Order around Most-Favored-Nation drug pricing argues that countries outside the US need to raise their prices on pharmaceuticals saying that many other countries are “freeloading” and paying less than their share for pharmaceuticals. In response, pharmaceutical companies have increased prices in the UK and even threatened to “walk away” from…
Startup Nilo Launches With $101M for Autoimmune Drugs That Target ‘Brain-Body Circuits’
Nilo Therapeutics’ Series A round was led by The Column Group, DCVC Bio, and Lux Capital. The preclinical startup is developing drugs targeting neural circuits that control systemic inflammation. The post Startup Nilo Launches With $101M for Autoimmune Drugs That Target ‘Brain-Body Circuits’ appeared first on MedCity News.
